An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI44656PMID 21403401PMCID PMC3069779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation

  2010cited by this paper
• Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

  2009cited by this paper
• Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature

  2009cited by this paper
• Modeling Adult Gliomas Using RCAS/t-va Technology.

  2009cited by this paper
• Duplication of 7q34 in Pediatric Low‐Grade Astrocytomas Detected by High‐Density Single‐Nucleotide Polymorphism‐Based Genotype Arrays Results in a Novel BRAF Fusion Gene

  2009cited by this paper
• Pediatric gliomas.

  2009cited by this paper
• Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

  2009cited by this paper
• Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas

  2009cited by this paper
• Constitutive activation of Raf-1 induces glioma formation in mice.

  2008cited by this paper
• BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.

  2008cited by this paper
• Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

  2008cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Mouse models for BRAF-induced cancers.

  2007cited by this paper
• V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors.

  2006cited by this paper
• Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.

  2005cited by this paper
• Dose-Dependent Effects of Platelet-Derived Growth Factor-B on Glial Tumorigenesis

  2004cited by this paper
• Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

  2002cited by this paper
• PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

  2001cited by this paper

• O-mannosylation and protein maturation check-points represent therapeutic opportunities in BRAF fusion protein oncogenesis

  2025cites this paper
• Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models

  2025cites this paper
• Rodent models of tumours of the central nervous system

  2024cites this paper
• Glioma

  2024cites this paper
• MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models

  2024cites this paper
• Pediatric low-grade glioma models: advances and ongoing challenges

  2024cites this paper
• Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.

  2023cites this paper
• BRAF Landscape and Its Implications among Patients with Pediatric Low-Grade Gliomas: A Comprehensive Review of the Literature

  2023cites this paper
• Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies

  2023cites this paper
• Neurofibromatosis type 1-associated gliomas and other tumors: A new pathway forward?

  2023cites this paper
• Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms

  2023cites this paper
• Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.

  2023cites this paper
• Oncogenic BRAFV600E induces microglial proliferation through extracellular signal-regulated kinase and neuronal death through c-Jun N-terminal kinase

  2022cites this paper
• LGG-50. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling

  2022influential citation
• Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models

  2022cites this paper
• Oncogenic BRAF V600E induces glial proliferation through ERK and neuronal death through JNK

  2021cites this paper
• Heterogeneity and excitability of BRAFV600E-induced tumors is determined by PI3K/mTOR-signaling state and Trp53-loss

  2021cites this paper
• Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis

  2021cites this paper
• Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss

  2021cites this paper
• A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-Driven Pediatric Low-Grade Glioma Cells

  2020cites this paper
• KIAA1549-BRAF Expression Establishes A Permissive Tumor Microenvironment Through NfÎob-Mediated CCL2 Production

  2020cites this paper
• BRAFV600E Expression in Mouse Neuroglial Progenitors Increase Neuronal Excitability, Cause Appearance of Balloon-like cells, Neuronal Mislocalization, and Inflammatory Immune response

  2019cites this paper
• 3 Important Pathways in Glioma Biology 3 . 1 RTK / RAS / PI ( 3 K ) , P 53 , Rb

  2019cites this paper
• Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines

  2019cites this paper
• Effects of Sorafenib and Arsenic Trioxide on U937 and KG-1 Cell Lines: Apoptosis or Autophagy?

  2019cites this paper
• Neurodevelopmental Aspects of RASopathies

  2019cites this paper
• Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis

  2018cites this paper
• The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma

  2018influential citation
• KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production

  2018cites this paper
• Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors

  2018cites this paper
• Pediatric low-grade gliomas: next biologically driven steps

  2018cites this paper
• CRISPR‐engineered genome editing for the next generation neurological disease modeling

  2018cites this paper
• Glioma: experimental models and reality

  2017influential citation
• BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas.

  2017cites this paper
• Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma

  2017cites this paper
• Recent Advances in Targeted Therapy for Glioma.

  2017cites this paper
• Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci

  2016cites this paper
• Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution

  2016cites this paper
• Low Grade Gliomas in Children

  2016cites this paper
• BRAF Mutations Open Doors for N-Ethyl-N-Nitrosourea-Induced Gliomagenesis.

  2016cites this paper
• Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing

  2016cites this paper
• Implications of mitogen‐activated protein kinase signaling in glioma

  2016influential citation
• Expression of Methylthioadenosine Phosphorylase (MTAP) in Pilocytic Astrocytomas

  2016cites this paper
• Pediatric gliomas as neurodevelopmental disorders

  2015cites this paper
• Glioma

  2015cites this paper
• Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma

  2015cites this paper
• Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas

  2015cites this paper
• The BRAF kinase domain promotes the development of gliomas in vivo

  2015cites this paper
• The impact of coexisting genetic mutations on murine optic glioma biology.

  2015cites this paper
• Basic Science of Pediatric Brain Tumors

  2015cites this paper
• Model-Based Evaluation of Spontaneous Tumor Regression in Pilocytic Astrocytoma

  2015cites this paper
• Glioma biology and molecular markers.

  2015cites this paper
• Expression of Methylthioadenosine Phosphorylase (MTAP) in Pilocytic Astrocytomas

  2015cites this paper
• Pilocytic astrocytoma: a review of genetic and molecular factors, diagnostic and prognostic markers.

  2014cites this paper
• Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein

  2014cites this paper
• Signals that regulate the oncogenic fate of neural stem cells and progenitors.

  2014cites this paper
• Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.

  2014cites this paper
• RAS/ERK Signaling Controls Proneural Genetic Programs in Cortical Development and Gliomagenesis

  2014influential citation
• The molecular and cell biology of pediatric low-grade gliomas

  2014cites this paper
• Conditional KIAA1549:BRAF mice reveal brain region‐ and cell type‐specific effects

  2013cites this paper
• Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

  2013cites this paper
• Pathological and molecular advances in pediatric low-grade astrocytoma.

  2013cites this paper
• Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.

  2013cites this paper
• Recent aspects of classification and epidemiology of epilepsy‐associated tumors

  2013cites this paper
• To BRAF or Not to BRAF: Is That Even a Question Anymore?

  2013cites this paper
• Long‐term outcome of centrally located low‐grade glioma in children

  2013cites this paper
• Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma

  2013cites this paper
• What underlies the diversity of brain tumors?

  2013influential citation
• Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.

  2012cites this paper
• RAF Fusion Genes and MAPK Activation in Pilocytic Astrocytomas

  2012cites this paper
• Biologically targeted therapeutics in pediatric brain tumors.

  2012cites this paper
• Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.

  2012cites this paper
• Low‐grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis‐1

  2012cites this paper
• Will kinase inhibitors make it as glioblastoma drugs?

  2012cites this paper
• The molecular biology of WHO grade I astrocytomas.

  2012cites this paper
• MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma

  2012cites this paper
• Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma

  2012cites this paper
• Therapeutic Kinase Inhibitors

  2012cites this paper
• Something old and something new about molecular diagnostics in gliomas.

  2012cites this paper
• Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy

  2012cites this paper
• MAPK pathway activation in pilocytic astrocytoma

  2011cites this paper
• Spontaneous regression of brain tumors in children: case report and literature review Regresión espontánea de tumores cerebrales en niños: Reporte de caso y revisión de la literatura

  year unknowncites this paper